National Health Investors (NYSE:NHI)‘s stock had its “hold” rating reaffirmed by research analysts at Mizuho in a research note issued to investors on Monday. They currently have a $70.00 target price on the real estate investment trust’s stock. Mizuho’s target price indicates a potential upside of 6.77% from the company’s current price.
A number of other research analysts have also issued reports on the company. Stifel Nicolaus set a $76.00 target price on National Health Investors and gave the company a “buy” rating in a report on Saturday, February 17th. SunTrust Banks set a $70.00 target price on National Health Investors and gave the stock a “hold” rating in a research report on Saturday, February 17th. They noted that the move was a valuation call. Hilliard Lyons raised National Health Investors from a “neutral” rating to a “buy” rating in a report on Friday, February 16th. Cantor Fitzgerald reissued a “hold” rating and set a $85.00 price target on shares of National Health Investors in a report on Friday, February 16th. Finally, ValuEngine lowered National Health Investors from a “buy” rating to a “hold” rating in a report on Friday, February 2nd. Two analysts have rated the stock with a sell rating, eight have given a hold rating and three have assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $77.75.
National Health Investors (NYSE NHI) traded down $0.75 during trading hours on Monday, reaching $65.56. The company had a trading volume of 143,712 shares, compared to its average volume of 277,935. The stock has a market capitalization of $2,741.12, a price-to-earnings ratio of 17.03, a PEG ratio of 2.99 and a beta of 0.41. National Health Investors has a 52-week low of $62.71 and a 52-week high of $81.60. The company has a debt-to-equity ratio of 0.87, a quick ratio of 13.85 and a current ratio of 13.85.
A number of institutional investors and hedge funds have recently modified their holdings of NHI. Jacobi Capital Management LLC grew its holdings in National Health Investors by 187.7% during the third quarter. Jacobi Capital Management LLC now owns 1,827 shares of the real estate investment trust’s stock valued at $142,000 after purchasing an additional 1,192 shares during the period. Fortaleza Asset Management Inc. raised its stake in National Health Investors by 123.7% in the 3rd quarter. Fortaleza Asset Management Inc. now owns 2,740 shares of the real estate investment trust’s stock valued at $212,000 after acquiring an additional 1,515 shares during the period. Zeke Capital Advisors LLC bought a new stake in National Health Investors in the 4th quarter valued at about $226,000. Cubist Systematic Strategies LLC bought a new stake in shares of National Health Investors during the third quarter valued at about $237,000. Finally, Stephens Inc. AR bought a new stake in shares of National Health Investors during the fourth quarter valued at about $238,000. Institutional investors own 70.12% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This report was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another publication, it was illegally copied and reposted in violation of United States & international trademark & copyright laws. The legal version of this report can be viewed at https://www.tickerreport.com/banking-finance/3224357/national-health-investors-nhi-stock-rating-reaffirmed-by-mizuho.html.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.